Hixon Zuercher’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Buy
1,765
+15
+0.9% +$15.3K 0.62% 54
2026
Q1
$1.61M Hold
1,750
0.5% 62
2025
Q4
$1.88M Sell
1,750
-39
-2% -$37.3K 0.57% 58
2025
Q3
$1.36M Hold
1,789
0.42% 65
2025
Q2
$1.39M Hold
1,789
0.45% 65
2025
Q1
$1.48M Buy
1,789
+12
+0.7% +$9.98K 0.52% 62
2024
Q4
$1.37M Hold
1,777
0.53% 60
2024
Q3
$1.57M Buy
1,777
+3
+0.2% +$2.7K 0.62% 54
2024
Q2
$1.61M Buy
1,774
+12
+0.7% +$9.6K 0.68% 47
2024
Q1
$1.37M Sell
1,762
-400
-19% -$285K 0.58% 51
2023
Q4
$1.26M Sell
2,162
-26
-1% -$15.2K 0.58% 46
2023
Q3
$1.18M Hold
2,188
0.62% 45
2023
Q2
$1.03M Hold
2,188
0.52% 49
2023
Q1
$751K Sell
2,188
-36
-2% -$12.1K 0.45% 43
2022
Q4
$814K Hold
2,224
0.5% 42
2022
Q3
$719K Sell
2,224
-6,078
-73% -$1.93M 0.46% 46
2022
Q2
$2.69M Sell
8,302
-993
-11% -$298K 1.74% 28
2022
Q1
$2.66M Sell
9,295
-273
-3% -$70.3K 1.43% 32
2021
Q4
$2.64M Buy
9,568
+162
+2% +$41.1K 1.33% 35
2021
Q3
$2.17M Buy
9,406
+24
+0.3% +$5.92K 1.27% 35
2021
Q2
$2.15M Sell
9,382
-8
-0.1% -$1.61K 1.3% 35
2021
Q1
$1.75M Buy
9,390
+105
+1% +$20.5K 1.16% 32
2020
Q4
$1.57M Sell
9,285
-102
-1% -$15.2K 1.09% 32
2020
Q3
$1.39M Buy
9,387
+172
+2% +$26.6K 1.07% 32
2020
Q2
$1.51M Buy
9,215
+7,065
+329% +$1.08M 1.3% 30
2020
Q1
$298K Hold
2,150
0.43% 29
2019
Q4
$283K Buy
+2,150
New +$249K 0.27% 47

Other funds holding LLY

Hixon Zuercher's LLY Position: Q2 2026 in Review

Hixon Zuercher increased its Eli Lilly (LLY) stake by 0.86% in Q2 2026, buying an estimated $15.3K and bringing the position to 1,765 shares worth $2.12M. The position accounts for 0.62% of the portfolio, ranked #54.

Hixon Zuercher first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.69M in Q2 2022. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hixon Zuercher held 1,765 shares of Eli Lilly worth $2.12M as of Q2 2026.
  • Hixon Zuercher bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.62% of Hixon Zuercher's portfolio in Q2 2026, its #54 holding.
  • Hixon Zuercher first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • Hixon Zuercher's Eli Lilly position peaked at $2.69M in Q2 2022.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hixon Zuercher's 13F filing for Q2 2026, filed 20 Jul 2026.